Cargando…
The inhibition of ORMDL3 prevents Alzheimer's disease through ferroptosis by PERK/ATF4/HSPA5 pathway
Alzheimer's disease (AD) is a neurodegenerative disease with high incidence and widespread attention. There is currently no clear clarification of the pathogenesis. However, ORMDL3 causes ferroptosis in AD, and the potential mechanisms remain unclear. So, this study explore the function of ORMD...
Autores principales: | Shao, Yankun, Xu, Yilin, Di, Huang, Shi, Xinxiu, Wang, Yingying, Liu, Hongyu, Song, Lina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10190607/ https://www.ncbi.nlm.nih.gov/pubmed/36680386 http://dx.doi.org/10.1049/nbt2.12113 |
Ejemplares similares
-
Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells
por: Chen, Yibing, et al.
Publicado: (2019) -
PERK/ATF3-Reduced ER Stress on high potassium environment in the suppression of tumor ferroptosis
por: Pu, Xufeng, et al.
Publicado: (2023) -
The role of ORMDL3/ATF6 in compensated beta cell proliferation during early diabetes
por: Yang, Weixia, et al.
Publicado: (2019) -
miRNA-1283 Regulates the PERK/ATF4 Pathway in Vascular Injury by Targeting ATF4
por: He, Ling, et al.
Publicado: (2016) -
HSPA5 Promotes the Proliferation, Metastasis and Regulates Ferroptosis of Bladder Cancer
por: Wang, Qinghua, et al.
Publicado: (2023)